All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99


COVID-19: Transmission, Laboratory Diagnosis and Treatment Options

DOI: 10.4236/oalib.1106496, PP. 1-9

Subject Areas: Infectious Diseases

Keywords: COVID-19, Transmission, Detection, Treatment Options, Vaccine

Full-Text   Cite this paper   Add to My Lib


Severe acute respiratory syndrome coronavirus 2 (SARS-COV2) the virus responsible for the outbreak of the 2020 pandemic at the Wuhan city in China belongs to the coronavirus family. While the disease rages, scientists are striving to discover drugs and vaccines to combat the virus. Person to person transmission has been the major source of transmission in respiratory droplets from an infected or an asymptomatic infected person to another and indirectly by virus contamination of objects. There has been no evidence of vertical transmission or transmission through blood and blood products. The virus can be detected in clinical specimens by electron microscopy, cell culture, real-time RT-PCR and next-generation sequencing. Therapeutic approaches to combat the infection have been supportive and preventive aimed at transmission reduction, but no specific drug candidate at the forefront for therapy. The race towards developing a vaccine for the disease has led to the discovery of 115 potential candidates. Databases such as Google Scholar, PubMed, MEDLINE and NCBI were searched to summarise the current state of knowledge to the global outbreak.

Cite this paper

Lawani-Luwaji, E. U. and Akhogba, A. O. (2020). COVID-19: Transmission, Laboratory Diagnosis and Treatment Options. Open Access Library Journal, 7, e6496. doi:


[1]  Lai, M.M. (2001) Coronaviridae: The Viruses and Their Replication. In: Knipe, D.M. and Howley, P.M., Eds., Fields Virology, Lippincott-Raven, Philadelphia, 1163-1186.
[2]  McIntosh, K. and Peiris, J. (2009) Coronaviruses. In: Richman, D.D., Whitley, R.J. and Hayden, F.G., Eds., Clinical Virology, Third Edition, American Society of Microbiology Press, Washington DC, 1155-1171.
[3]  Korsman, S.N., Van Zyl, G., Preiser, W., Nutt, L. and Andersson, M.I. (2012) Virology E-Book: An Illustrated Colour Text. Elsevier Health Sciences, Amsterdam.
[4]  Masters, P.S. (2006) The Molecular Biology of Coronaviruses. Advances in Virus Research, 66, 193-292.
[5]  Van der Most, R.G., Luytjes, W., Rutjes, S. and Spaan, W.J. (1995) Translation But Not the Encoded Sequence Is Essential for the Efficient Propagation of the Defective Interfering RNAs of the Coronavirus Mouse Hepatitis Virus. Journal of Virology, 69, 3744-3751.
[6]  Woo, P.C., Lau, S.K., Chu, C., Chan, K., Tsoi, H., Huang, Y., Wong, B.H., Poon, R.W., Cai, J.J. and Luk, W. (2005) Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia. Journal of Virology, 79, 884-895.
[7]  Lau, S.K., Woo, P.C., Li, K.S., Huang, Y., Tsoi, H., Wong, B.H., Wong, S.S., Leung, S., Chan, K. and Yuen, K. (2005) Severe Acute Respiratory Syndrome Coronavirus-Like Virus in Chinese Horseshoe Bats. Proceedings of the National Academy of Sciences, 102, 14040-14045.
[8]  Li, W., Shi, Z., Yu, M., Ren, W., Smith, C., Epstein, J.H., Wang, H., Crameri, G., Hu, Z. and Zhang, H. (2005) Bats Are Natural Reservoirs of SARS-Like Coronaviruses. Science, 310, 676-679.
[9]  Rothan, H.A. and Byrareddy, S.N. (2020) The Epidemiology and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak. Journal of Autoimmunity, 109, 102433-102436.
[10]  Wang, W., Tang, J. and Wei, F. (2020) Updated Understanding of the Outbreak of 2019 Novel Coronavirus (2019 nCoV) in Wuhan, China. Journal of Medical Virology, 92, 441-447.
[11]  Li, W., Moore, M.J., Vasilieva, N., Sui, J., Wong, S.K., Berne, M.A., Somasundaran, M., Sullivan, J.L., Luzuriaga, K. and Greenough, T.C. (2003) Angiotensin-Converting Enzyme 2 Is a Functional Receptor for the SARS Coronavirus. Nature, 426, 450-454.
[12]  Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J. and Gu, X. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, 395, 497-506.
[13]  Carlos, W.G., Cruz, D., Pasnick, S., Jamil, S., et al. (2020) Novel Wuhan (2019-nCoV) Coronavirus. American Journal of Respiratory and Critical Care Medicine, 201, 7-8.
[14]  Cai, J., Sun, W., Huang, J., Gamber, M., Wu, J. and He, G. (2020) Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020. Emerging Infectious Diseases, 26, 1343-1345.
[15]  Chen, H., Guo, J., Wang, C., Luo, F., Yu, X., Zhang, W., Li, J., Zhao, D., Xu, D. and Gong, Q. (2020) Clinical Characteristics and Intrauterine Vertical Transmission Potential of COVID-19 Infection in Nine Pregnant Women: A Retrospective Review of Medical Records. The Lancet, 395, 809-815.
[16]  Chang, L., Yan, Y. and Wang, L. (2020) Coronavirus Disease 2019: Coronaviruses and Blood Safety. Transfusion Medicine Reviews.
[17]  Zhou, P., Yang, X., Wang, X., Hu, B., Zhang, L., Zhang, W., Si, H., Zhu, Y., Li, B. and Huang, C. (2020) A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature, 579, 270-273.
[18]  Wu, Z. and McGoogan, J.M. (2020) Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA, 323, 1239-1242.
[19]  Wan, Y., Shang, J., Graham, R., Baric, R.S. and Li, F. (2020) Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Journal of Virology, 94, e00127-20.
[20]  Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T.S., Herrler, G., Wu, N. and Nitsche, A. (2020) SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 181, 271-280.
[21]  Mason, R.J. (2020) Pathogenesis of COVID-19 from a Cell Biology Perspective. European Respiratory Journal, 55, Article ID: 2000607.
[22]  Thompson, B.T., Chambers, R.C. and Liu, K.D. (2017) Acute Respiratory Distress Syndrome. New England Journal of Medicine, 377, 562-572.
[23]  Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W. and Lu, R. (2020) China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England Journal of Medicine, 382, 727-733.
[24]  Xie, X., Zhong, Z., Zhao, W., et al. (2020) Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing. Radiology.
[25]  Lamb, L.E., Bartolone, S.N., Ward, E. and Chancellor, M.B. (2020) Rapid Detection of Novel Coronavirus (COVID19) by Reverse Transcription-Loop-Mediated Isothermal Amplification.
[26]  Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S.C. and Di Napoli, R. (2020) Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls Publishing, Treasure Island.
[27]  Gao, J., Tian, Z. and Yang, X. (2020) Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies. Bioscience Trends, 14, 72-73.
[28]  Gautret, P., Lagier, J., Parola, P., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V.E. and Dupont, H.T. (2020) Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial. International Journal of Antimicrobial Agents.
[29]  Lim, J., Jeon, S., Shin, H., Kim, M.J., Seong, Y.M., Lee, W.J., Choe, K., Kang, Y.M., Lee, B. and Park, S. (2020) Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: The Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR. Journal of Korean Medical Science, 35, e79.
[30]  Yanai, H. (2020) Favipiravir: A Possible Pharmaceutical Treatment for COVID-19. Journal of Endocrinology and Metabolism, 10, 33-34.
[31]  Dong, L., Hu, S. and Gao, J. (2020) Discovering Drugs to Treat Coronavirus Disease 2019 (COVID-19). Drug Discoveries & Therapeutics, 14, 58-60.
[32]  Mahase, E. (2020) COVID-19: What Treatments Are Being Investigated? British Medical Journal, 368, m1252.
[33]  Lane, R. (2020) Sarah Gilbert: Carving a Path towards a COVID-19 Vaccine. The Lancet (London, England), 395, 1247.
[34]  Le, T.T., Andreadakis, Z., Kumar, A., Roman, R.G., Tollefsen, S., Saville, M. and Mayhew, S. (2020) The COVID-19 Vaccine Development Landscape. Nature Reviews Drug Discovery, 19, 305-306.
[35]  Sohrabi, C., Alsafi, Z., O'Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Iosifidis, C. and Agha, R. (2020) World Health Organization Declares Global Emergency: A Review of the 2019 Novel Coronavirus (COVID-19). International Journal of Surgery, 76, 71-76.


comments powered by Disqus

Contact Us


微信:OALib Journal